Stockreport

Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study [Yahoo! Finance]

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com
PDF Statistically significant 22% higher ORR and 2.6 month longer PFS in patients who had not had prior anti-VEGF therapy Leap to host a conference call to present clinic [Read more]